This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
Chief Executive Officer
none not applicable
Chief Executive Officer and Chief Financial Officer and Chief Operating Officer
Business & Commerce
University of Mary Washington
Masterâ€™s degree MA
Management & Leadership
Immune Response BioPharma Files Amended FDA BLA for Remune - PR.com
"IRBP values NeuroVax north of a billion dollar of annual sales once approved.
We will find a solid partner or raise capital on our own, we don't need GSK which has zer0 experience in multiple sclerosis or auto-immune diseases.
GSK is a joke and seems very ignorant on how multiple sclerosis drugs work and how to develop one, we gave them a chance to develop NeuroVax but their management appears to be very poor.
We have decided to terminate any collaboration or development with GSK.
Tolko Industries Ltd
C&S Wholesale Grocers Inc
Peoples National Bank
Seattle City Council